Scientific Research and Experimental Development Tax Credit Program

We talk about anchor companies all the time at, at Biotech Canada.

I would love to be able to be truly celebrating an anchor company that has grown up in Canada because we have put in place, whether it's patent box, whether it's tax incentives, whether it's we've included increase the SR&ED and the VCCI, and all these different ways of supporting these early stage companies so that they can get past that big hurdle, get to commercialization, set up their manufacturing here, and we can have a Novo Nordisk here in Canada, um, in the future.

So I would just like you...

That's not gonna happen in the next 18 to 24 months, but we can be celebrating the decisions and the changes in policy that government can put in place t-to support that in the future.

As well as there are government plans within-- with all, all over the world.

I know specifically in Canada, we have something called SR&ED or S-R-E-D. It's actually required almost within the plan to make a failure.

So that failure shows that you are doing something different than the rest of the world or the industry is not doing, and now I'll give you money back for it.

So there's, there's ways that you can even as, as a, as an organization, that you can find ways to fund them.

The example given is the year 2020 and produces long silences.

And issue 75 specifically calls out an acronym SR&ED as a token that produces UNC output.

So the model doesn't just say it wrong.

It goes quiet.